
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.01 | 1.22 | 0.21 |
Shares | 98.99 | 99.01 | 0.02 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.46 | 19.61 |
Price to Book | 3.76 | 3.84 |
Price to Sales | 2.05 | 2.22 |
Price to Cash Flow | 12.45 | 14.84 |
Dividend Yield | 2.15 | 1.50 |
5 Years Earnings Growth | 7.93 | 10.20 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.54 | 94.36 |
Basic Materials | 0.39 | 2.08 |
Consumer Defensive | 0.04 | 3.33 |
Financial Services | 0.03 | 7.76 |
Number of long holdings: 181
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.29 | 761.50 | -3.58% | |
J&J | US4781601046 | 5.33 | 162.98 | -1.09% | |
AbbVie | US00287Y1091 | 4.66 | 191.40 | +0.43% | |
UnitedHealth | US91324P1021 | 3.96 | 288.07 | -1.51% | |
Abbott Labs | US0028241000 | 3.27 | 120.51 | -8.52% | |
Novartis | CH0012005267 | 3.24 | 92.45 | -0.95% | |
Roche Holding Participation | CH0012032048 | 3.22 | 258.90 | +0.74% | |
Novo Nordisk B | DK0062498333 | 3.11 | 423.7 | -0.07% | |
Intuitive Surgical | US46120E6023 | 2.77 | 516.16 | +0.69% | |
Merck&Co | US58933Y1055 | 2.77 | 81.52 | -1.10% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust F Acc | 7.6B | -6.94 | 11.55 | 13.45 | ||
Legal General US Index Trust F Dist | 7.6B | -6.90 | 11.55 | 13.45 | ||
Legal General US Index Trust C Acc | 7.46B | -9.46 | 8.17 | 13.30 | ||
Legal General US Index Trust C Dist | 7.46B | -9.51 | 8.16 | 13.29 | ||
International Index Trust I Acc | 7.46B | -0.17 | 13.97 | 12.34 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review